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A B S T R A C T
Background: Legionella pneumophila is the main cause for community-acquired pneumonia especially in hospital
environments. In this systematic review and meta-analysis, we evaluated the prevalence of L. pneumophila in
clinical samples obtained from Iranian patients.
Methods: The studies reporting L. pneumophila prevalence in Iranian clinical samples that were published be-
tween January 2000 and July 2016 were recruited. Comprehensive Meta-Analysis Software (version 3.3.070)
was used for quantitative data analysis. Because of high heterogeneity between the studies according to the
Cochrane Q and I2 statistics, a random-eﬀects model was used for meta-analysis.
Results: Sixteen studies encompassing 1956 subjects were included in the meta-analysis. The overall prevalence
of L. pneumophila was 9.6% in clinical samples obtained from the Iranian patients. The age spectrum ranged from
6 months to 80 years old. Dyspnea and cough comprised the most common clinical manifestations. In the
subgroup analysis, the prevalence of L. pneumophila was higher in studies with sample size ≤100 (12.9%) in
comparison with studies with sample size> 100 (8.4%). In addition, the prevalence of L. pneumophila was
higher in the years 2009–2016 (9.2%) compared with 2000–2008 (0.7%).
Conclusion: L. pneumophila is a major cause of community- and hospital-acquired pneumonia. It is of pivotal
importance to implement sensitive and reliable molecular and culture-based techniques to detect and control
this infection in healthcare environments.
1. Introduction
Legionella species are responsible for around 30% of hospital-ac-
quired pneumonia (HAP) and nearly 1–3% of community-acquired
pneumonia (CAP) [1]. Legionella pneumophila is a small Gram-negative
bacillus responsible for about 2–15% of CAP and HAP respectively [1].
The bacterium is an aerobic, fastidious and motile organism with uni-
polar ﬂagella and pili lacking capsule and unable to form spores [2].
The infection aﬀects the respiratory system and is transmitted through
the respiratory route [3]. This agent particularly grows in hospital en-
vironments rendering a potential for hospital-borne infection [4]. L.
pneumophila is responsible for around 85% of Legionnaires' disease
cases which can be either sporadic or epidemic [5]. The ﬁrst global
outbreak of hospital-acquired Legionnaires’ disease was reported in
1976. The disease is mainly transmitted through micro-aspiration [6].
Although L. pneumonia infection has no speciﬁc clinical signs and
symptoms [7], it may manifest with diarrhea, neurological problems
(especially confusion), fever (usually higher than 39 °C), hyponatremia,
hepatic dysfunction and hematuria [8]. Community acquired pneu-
monia usually presents more severe clinical manifestations compared to
hospital acquired disease. This may be due to the relatively late diag-
nosis of the community-based disease leading to delayed therapeutic
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and antibiotic interventions. In the absence of proper antibiotic treat-
ment, legionellosis can impose high mortality and morbidity rates (as
high as 80%), particularly in immunosuppressed individuals [5] and
those co-infected with other respiratory pathogens such as Streptococcus
pneumoniae, Haemophilus inﬂuenzae and Mycobacterium tuberculosis. The
early diagnosis and timely initiation of the 14-day treatment course of
Legionella infections can prevent such potential health threats. Although
patients with a competent immune system appropriately respond to the
treatment, patients with a compromised immune system generally fail
to respond [9].
Determining the L. pneumophila prevalence and its contaminating
sources in hospital environments are necessary to manage the infection
and to evaluate the eﬀectiveness of the coping strategies. There has
been no systematic reviews on the prevalence of L. pneumophila in Iran.
Hence, we aimed to determine the prevalence of L. pneumophila in
clinical samples obtained from Iranian patients using a systematic re-
view and meta-analysis of published data.
2. Methods
2.1. Search strategy
The Prisma protocol (PRISMA, http://www.prisma-statement.org)
was followed in all steps of the study. The literature search was con-
ducted in PubMed, Scopus, Web of Science, Cochrane Library,
ScienceDirect, MEDLINE, Google Scholar as well as Iranian Scientiﬁc
Information Database (www.sid.ir), Iranmedex (www.iranmedex.com),
Magiran (www.magiran.com) and Irandoc (www.irandoc.ac.ir). The
keywords included Legionella, Legionnaires’ disease, incidence, epide-
miology, hospital-acquired pneumonia, community-acquired pneu-
monia, prevalence, L. pneumophila, Legionella spp, Legionella infection,
distribution and Iran. Also, the Persian equivalents of the keywords
were used in Iranian databases. Those studies reporting the prevalence
of L. pneumophila in clinical samples from Iranians patients and pub-
lished from January 2000 to July 2016 were included. The research
articles published in either English or Persian were recruited. The lit-
erature search was independently conducted by two professional and
experienced researchers. Finally, those studies meeting the eligibility
Fig. 1. Flow chart showing studies that were processed for inclusion in this study.
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criteria were included in the systematic review and met-analysis.
2.2. Inclusion and exclusion criteria
Original research papers (either cross-sectional, cohort or observa-
tional studies) reporting the distribution and prevalence of Legionella in
Iranian populations published from January 2000 to July 2016 were
included in this study. The review articles (either narrative or meta-
analysis and systematic reviews), letters to the editors, case reports,
congress papers, meeting abstracts and brief reports, articles presented
in languages other than English or Persian, as well as animal studies
and those conducted on environmental samples were excluded.
Furthermore, duplicate publications, unpublished studies and studies
with incomplete data and unclear methods, as well as studies with
sample sizes less than 50 were also excluded from the study.
2.3. Data extraction
The name of the ﬁrst author, publication year, location of the study,
patients’ age, and the prevalence of Legionellosis were recorded using a
researcher-designed data checklist. The extracted data was ﬁnally ver-
iﬁed by the study supervisor.
2.4. Statistical analysis
The Comprehensive Meta-Analysis Software (Version 3.3.070) was
used for data analysis. The prevalence of L. pneumophila was reported
by 95% conﬁdence intervals (CIs). Because of the heterogeneity be-
tween the studies as determined by the Cochrane Q and I2 tests, a
random-eﬀects model was used for meta-analysis. The Egger's regres-
sion test and funnel plot were used to assess the presence of any pub-
lication bias considering a P < 0.05 as the statistical signiﬁcance
threshold. In addition, the Egger's linear Regression Test was used to
assess the likelihood of missing the studies on funnel-plot asymmetry.
3. Results
3.1. Study characteristics
As shown in Fig. 1, a total of 3479 studies were identiﬁed after the
primary search in English and Persian databases. Out of these, 174 full
texts were evaluated from which 16 studies were considered eligible to
be included in the meta-analysis. All of the eligible studies were con-
ducted on clinical samples and in diﬀerent geographical areas of Iran;
most of them (n= 9) conducted in Tehran city. Phenotypic as well as
molecular and biochemical detection techniques which were used in
the studies included morphology and smear microscopy, BCYE-a
medium culture, PCR-based methods (Nested PCR, real-time PCR),
DFA, ELISA and Latex agglutination. PCR-based techniques were the
most commonly used molecular method. The clinical samples included
BAL, urine, sputum as well as respiratory and lung secretions (see Fig. 2
and Fig. 3).
According to the meta-analysis, the prevalence of Legionella varied
from 0.4% to 22.1% (Table 1 and Fig. 1). The largest sample size was
related to the study by Fard et al. and the smallest belonged to the
studies carried out by Mirkalantari et al. and Hosseini Dust et al. To-
tally, 1956 clinical samples were analyzed. The patients' age spectrum
widely varied from 6 months to 80 years old encompassing neonates,
children, adolescents, young adults, and elderly. Dyspnea and cough
comprised the most common clinical manifestations in the patients.
Other clinical presentations included Legionnaires’ disease, COPD,
asthma, respiratory infections, pneumonia, HAP and CAP.
3.2. Overall eﬀects
As there was a signiﬁcant heterogeneity between the sixteen
included studies (Q2=63.4, I2= 76.3, t=41, p=0.000), a random-
eﬀects model was used to estimate the combined prevalence of L.
pneumophila. Overall, the prevalence of L. pneumophila in Iranian clin-
ical samples was estimated to be 9.6% (95% Cl: 8.2, 11.1). The funnel
plot test and the Egger's test (p=0.00) indicated publication bias in the
evaluated studies (p=0.00).
3.3. L. pneumophila prevalence in subgroup analyses
Subgroups analysis showed that the prevalence of L. pneumophila in
clinical samples obtained from the Iranian patients was higher in stu-
dies with sample siz e≤ 100 in comparison with studies with sample
size> 100 (12.9%, 95% CI: 9.9–16.7 vs. 8.4%, 95% CI: 7.0–10.1 (re-
spectively. Also, subgroup analysis based on the study locations showed
that the highest prevalence of L. pneumophila was observed in Ahvaz
(17.4%, 95% CI: 11.6–25.2) and Shahrekord (12.0%, 95% CI: 8.5–16.6)
cities. Subgroup analysis regarding the time of the studies revealed that
the prevalence of L. pneumophila was higher in the years 2009–2016
(9.2%, 95% CI: 7.7–11.0) compared with the 2000–2008 (0.7%, 95%
CI: 8.0–14.3) period (Table 2).
4. Discussion
Our aim was to assess the prevalence of L. pneumophila in clinical
samples obtained from Iranian patients. To this end, we conducted a
systematic review and meta-analysis of studies conducted in diﬀerent
areas of the country. Studies published on the prevalence of L. pneu-
mophila in clinical samples obtained from Iranian patients from January
2000 to July 2016 were included in our review. The overall prevalence
of L. pneumophila was 9.6% (95% Cl: 8.2–11.1). The prevalence varied
from 0.4% to 22.1% in diﬀerent reports. This ﬁnding is inconsistent
with other studies from diﬀerent regions of the world [10–12].
Such inconsistencies may partly be related to the variations in cli-
mate conditions, exposition to contaminating sources (such as water),
the penetrance of Legionella in the normal population [13], smoking
frequency, the co-presence of other infectious diseases (such as chronic
respiratory disease or other underlying chronic conditions), and ﬁnally
the immune system competency [14].
Our results revealed that PCR-based methods were the most
common molecular techniques used for detecting L. pneumophila in
Iranian patients. Besides that PCR-based techniques are fast diagnostic
approaches, these methods have unique features such as high sensitivity
to detect even dead bacteria which are undetectable by culture-based
methods, as well as the ability to detect a single organism by DNA
ampliﬁcation [15].
Subgroup analysis considering the time of the studies revealed that
the prevalence of L. pneumonia was higher in the years 2009–2016
compared to 2000–2008 with frequencies of 9.2% (95% CI: 7.7–11.0)
and 0.7% (95% CI: 8.0–14.3), respectively. This observation may partly
be due to the development of diagnostic techniques with higher sensi-
tivities in the recent years. Furthermore, and regarding the important
role of this bacterium in pneumonia, extensive epidemiological studies
have been conducted on this agent in the recent decade.
Subgroup analysis based on the location of the studies showed that
the highest prevalence of L. pneumophila was observed in Ahvaz city.
This observation can be related to the speciﬁc climate condition in this
city that follows a biphasic pattern. In this biphasic pattern, the climate
is much warmer during the ﬁrst six months of the year compared to the
second six months. This necessitates using air conditioners to cool the
ambient temperature which exposes the people to L. pneumophila
transmitted through these systems [16].
Interestingly, only the L. pneumophila serotype 1 was reported by all
of the evaluated studies. In fact, molecular techniques have now pro-
vided sensitive methods to detect L. pneumophila serotype 1 in the
context of Legionnaires’ disease. Accordingly, most of the evaluated
studies were carried out for detecting this serotype [17].
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As a limitations of this study, the prevalence of L. pneumophila ob-
tained here may not be generalizable to the whole country as this was
based on the data recruited from some regions sparing other areas for
which we found no reports.
5. Conclusion
The overall prevalence of L. pneumophila was 9.6% (95% Cl:
8.2–11.1), ranging from 0.4% to 22.1% in diﬀerent studies. L.
Fig. 2. Forest plot of the meta-analysis for the prevalence of L. pneumophila in Iranian clinical samples.
Fig. 3. Funnel plot for meta-analysis of the prevalence of L. pneumophila in Iranian clinical samples.
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pneumophila is a major cause of community- and hospital-acquired
pneumonia. It is of pivotal importance to recruit sensitive and reliable
molecular and culture-based techniques to detect and control this in-
fection in healthcare environments.
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